Companies / Cullinan Therapeutics, Inc. / Activity

Activity — Cullinan Therapeutics, Inc.

30 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 20, 2026Ahmed Nadim
CEO
SellCommon Stock$223.1K-16K
-3.89%
404,318
0.63% of shares
medium
Feb 24, 2026Ahmed Nadim
CEO
SellCommon Stock$195.6K-14K
-3.34%
390,803
0.61% of shares
medium
Mar 5, 2026Michaelson Jennifer
Executive
SellCommon Stock$125.4K-8K
-4.47%
170,844
0.27% of shares
medium
Feb 20, 2026Michaelson Jennifer
Executive
SellCommon Stock$114.4K-8K
-4.21%
181,977
0.28% of shares
medium
Feb 20, 2026Jones Jeffrey Alan
Executive
SellCommon Stock$67.9K-5K
-2.94%
164,550
0.26% of shares
low
Feb 24, 2026Jones Jeffrey Alan
Executive
SellCommon Stock$66.3K-5K
-2.78%
159,968
0.25% of shares
low
Feb 20, 2026Fenton Mary Kay
Executive
SellCommon Stock$59.9K-4K
-3.36%
126,380
0.20% of shares
low
Feb 24, 2026Sumer Jacquelyn L
Executive
SellCommon Stock$52.1K-4K
-2.73%
128,089
0.20% of shares
low
Feb 24, 2026Michaelson Jennifer
Executive
SellCommon Stock$52.1K-4K
-2.00%
176,624
0.27% of shares
low
Feb 20, 2026Sumer Jacquelyn L
Executive
SellCommon Stock$51.0K-4K
-2.76%
131,690
0.20% of shares
low
Feb 20, 2026Michaelson Jennifer
Executive
SellCommon Stock$51.0K-4K
-2.01%
181,977
0.28% of shares
low
Jan 22, 2026Michaelson Jennifer
Executive
SellCommon Stock$49.2K-4K
-3.02%
128,635
0.20% of shares
low
Feb 20, 2026Michaelson Jennifer
Executive
ExerciseCommon Stock$34.4K+8K
+4.40%
189,977
0.30% of shares
low
Feb 25, 2026Michaelson Jennifer
Executive
SellCommon Stock$25.2K-2K
-1.01%
174,844
0.27% of shares
low
Feb 23, 2026Michaelson Jennifer
Executive
SellCommon Stock$24.5K-2K
-0.96%
180,225
0.28% of shares
low
Mar 5, 2026Michaelson Jennifer
Executive
ExerciseCommon Stock$17.2K+4K
+2.29%
178,844
0.28% of shares
low
Feb 12, 2026Michaelson Jennifer
Executive
SellCommon Stock$5.0K-416
-0.32%
128,219
0.20% of shares
low
Dec 31, 2025Fenton Mary Kay
Executive
GrantCommon Stock$175+27
+0.04%
62,028
0.10% of shares
low
Feb 18, 2026Michaelson Jennifer
Executive
GrantCommon Stock$0+58K
+44.85%
185,719
0.29% of shares
low
Feb 18, 2026Fenton Mary Kay
Executive
GrantCommon Stock$0+69K
+110.84%
130,778
0.20% of shares
low
Jun 16, 2026Allen Andrew R
Director
GrantStock Option (Right to Buy)+22K
21,781
0.03% of shares
low
Jun 16, 2026Thistle Mary
Director
GrantStock Option (Right to Buy)+25K
25,319
0.04% of shares
low
Feb 18, 2026Sumer Jacquelyn L
Executive
GrantStock Option (Right to Buy)+230K
230,000
0.36% of shares
low
Mar 5, 2026Michaelson Jennifer
Executive
ExerciseStock Option (Right to Buy)-4K
-3.20%
120,987
0.19% of shares
low
Feb 20, 2026Michaelson Jennifer
Executive
ExerciseStock Option (Right to Buy)-8K
-6.02%
124,987
0.19% of shares
low
Feb 18, 2026Michaelson Jennifer
Executive
GrantStock Option (Right to Buy)+115K
115,000
0.18% of shares
low
Feb 18, 2026Savill Corrine
Executive
GrantStock Option (Right to Buy)+175K
175,000
0.27% of shares
low
Feb 18, 2026Jones Jeffrey Alan
Executive
GrantStock Option (Right to Buy)+300K
300,000
0.47% of shares
low
Feb 18, 2026Ahmed Nadim
CEO
GrantStock Option (Right to Buy)+828K
828,000
1.29% of shares
low
Feb 18, 2026Fenton Mary Kay
Executive
GrantStock Option (Right to Buy)+138K
137,500
0.21% of shares
low
← PrevPage 1 of 1Next →